Obesity drug giant Eli Lilly on Thursday reported a monster first quarter, fortifying our conviction to stick with the stock after a period of sluggishness.
Read more
Verify All Oil Trade Documents
Obesity drug giant Eli Lilly on Thursday reported a monster first quarter, fortifying our conviction to stick with the stock after a period of sluggishness.
Read more
In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first
Read more